Company / Gross Profit
ResMed Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$3.1B
FY2025
5-year range
$1.8B / $3.1B
FY2021-FY2025
Trend
+15.1%
vs FY2024
Sector context
#16 of 95
Health Care
What the data says
ResMed's gross profit of $3.1B is higher than 83% of companies in the Health Care sector (FY2025). Gross Profit has increased for 9 consecutive years, from $1.1B in FY2016 to $3.1B in FY2025.
Based on SEC 10-K filings.
$3.1B in FY2025 with a 5-year CAGR of +12.2%. Top quartile in the Health Care sector.
Improved from $2.4B to $3.1B over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +14.7%
- 5-Year CAGR
- +12.2%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 95This company $3.1B Sector average $1.9B
▼
+63.0% above sector average
Key checks
Key Insights
- ResMed's gross profit has grown for 9 consecutive years.
- 5-year CAGR of +12.2%, indicating consistent growth.
- In FY2025, gross profit increased 15.1% year-over-year.
- Ranks #16 out of 95 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.1B | +15.1% |
| FY2024 | $2.7B | +12.7% |
| FY2023 | $2.4B | +16.4% |
| FY2022 | $2.0B | +10.1% |
| FY2021 | $1.8B | +7.1% |
| FY2020 | $1.7B | +15.0% |
| FY2019 | $1.5B | +11.9% |
| FY2018 | $1.3B | +11.1% |
| FY2017 | $1.2B | +12.7% |
| FY2016 | $1.1B | +5.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026